Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,208
Total Claims
$692K
Drug Cost
636
Beneficiaries
$1,088
Cost/Patient
Risk Score Breakdown 13/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-94%
Opioid rate vs peers
0.1% vs 2.2% avg
-23%
Cost per patient vs peers
$1,088 vs $1,411 avg
-1%
Brand preference vs peers
10.5% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.1%
Opioid Rate
20
Opioid Claims
$207
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,471 claims · $526K
Generic: 12,566 claims · $160K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Nph Human Isophane | 155 | $50K |
| Apixaban | 57 | $49K |
| Insulin Nph Hum/Reg Insulin Hm | 114 | $37K |
| Empaglifloz/Linaglip/Metformin | 50 | $34K |
| Levothyroxine Sodium | 229 | $24K |
| Ticagrelor | 21 | $23K |
| Dapagliflozin Propanediol | 17 | $23K |
| Empagliflozin/Metformin Hcl | 22 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 47 | $18K |
| Linagliptin | 14 | $18K |
| Rivaroxaban | 15 | $16K |
| Empagliflozin/Metformin Hcl | 11 | $15K |
| Losartan Potassium | 677 | $14K |
| Insulin Nph Hum/Reg Insulin Hm | 16 | $13K |
| Sitagliptin Phos/Metformin Hcl | 13 | $12K |
Prescribing Profile
Patient Profile
73
Avg Age
52%
Female
2.48
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About